Pharmaceutical Desiccant Market Growth, Size, Share, Trends, Demand by Segmentation, Top Key Player and Analysis by 2027

 Pharmaceutical Desiccant Market  - Overview

The Pharmaceutical Desiccant Market    is very dynamic in nature and is expected to witness high growth over the forecast period. The growth of the Pharmaceutical Desiccant Market    is influenced by growing pharmaceutical industry, increase in ageing population, and government initiative for pharmaceutical industry whereas it is hindered by the stringent regulations and temperature fluctuation.  

The continuous growth in the pharmaceutical industry is fuelling the overall growth of the Pharmaceutical Desiccant Market   . The rapid growth of the pharmaceutical market is mainly driven by the rising income and economic gains. The rise in the income, especially for the lower income level, along with the government commitments for providing basic health facilities, will make medicines available and affordable for the population. This will lead to the growth of pharmaceutical industry and indirectly will lead to more usage of pharmaceutical desiccant.

Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/4182

The rise in the ageing population leads to increasing diseases and more requirement of medical facilities in the population. This will increase the usage of medical facilities and health care products. Due to this, there will be an increase in the production of pharmaceutical desiccants. People are becoming aware about the diseases occurring due to growing age and are using the products which are healthy for them.

Government of India has taken various initiatives to ensure the approval, safety and marketing of quality drugs. The Central Drug Standards and Control Organization (CDSCO) provides the standards and measures for safety of the drugs, and ensures quality of the drug. It also regulates the market authorization of new drugs and approves the license for the manufacture of the drug. Due to the above regulatory bodies, there is an increase in the reliability of pharmaceutical products, which has resulted in the increased use of pharmaceutical desiccants. 

Key Players:

E. I. du Pont de Nemours and Company (U.S.), Multisorb Technologies (U.S.), Sanner GmbH (Germany), CSP Technologies, Inc (U.S.), Capitol Scientific, Inc (U.S.), Desiccare, Inc (U.S.), W. R. Grace & Co (U.S.), Desican Inc (U.S.), Clariant Global (Switzerland), and Oker-Chemie GmbH (Germany) are some of the prominent players at the forefront of competition in the global Pharmaceutical Desiccant Market    and are profiled in MRFR Analysis.

Browse Full Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-desiccant-market-4182

Global Pharmaceutical Desiccant Market      - Competitive Analysis

The major market players adopted various strategies to retain and/or expand their market share. Key strategies followed by most companies within the global Pharmaceutical Desiccant Market    were new product development. T

he major players operating in this market, to have adopted these strategies are E. I. du Pont de Nemours and Company (U.S.), Multisorb Technologies (U.S.), Sanner GmbH (Germany), CSP Technologies, Inc (U.S.), Capitol Scientific, Inc (U.S.), Desiccare, Inc (U.S.), W. R. Grace & Co (U.S.), Desican Inc (U.S.), Clariant Global (Switzerland), Oker-Chemie GmbH (Germany) and others. This strategy is widely adopted to increase the number of offerings to the customer. New innovations in the technology of manufacturing desiccants also lead to new product developments.      

During the period 2014-2016, amongst all the key developments, E. I. du Pont de Nemours and Company (U.S.) had the largest share of the merger and acquisition strategy. For instance, E. I. du Pont de Nemours and Company (U.S.) acquired Taxon Biosciences, Inc. (California), a leading microbiome discovery company. This acquisition will build on DuPont’s in-house capabilities and unparalleled market access in both seed and crop protection to discover and commercialize biological solutions for agriculture customers globally. The unique technology platform of Taxon Biosciences, Inc. coupled with DuPont’s robust research capabilities and positioning across several markets makes, the integration of Taxon into DuPont, a natural fit and will support DuPont’s ability to bring new products to the market, faster.

Clariant Global adopted joint ventures as its key strategy. The company has undergone joint ventures with ASK Group, Scientific Design Company Inc., Süd-Chemie India Pvt Ltd and others. For instance, the company underwent a joint venture with Scientific Design Company Inc., U.S., a producer of ethylene and oxide catalysts, which is co-owned by the Saudi Arabia-based, Sabic Group and has around 140 employees.

CSP Technologies, Inc. adopted new product development as its key strategy. For instance, the company introduced Pharmapuck™ Scavenging Devices, an Integrated Solution for Oral Solid Dose Products. It can be integrated directly into primary containers to protect oral solid dose (OSD) products from moisture and oxygen absorption.

Global Pharmaceutical Desiccant Market      - Segments

Global Pharmaceutical Desiccant Market    is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.

Segmentation By Type: Comprises – Silica Gel, Activated, Carbonclay Desiccant, Molecular Sieves and Others

Segmentation By End-use:  Comprises – Tablets, API’s, Capsules, Diagnostic Kit and Nutraceutical Product Packaging

Segmentation By Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World

Global Pharmaceutical Desiccant Market      - Regional Analysis

On the basis of region, North America region dominates the Pharmaceutical Desiccant Market   . High adoption of desiccants for pharmaceutical and chemical sectors helped the North America desiccant market stay ahead of other regional markets.

Europe was the second-largest market in 2015. Latest developments in healthcare sector and the strategies behind them to new marketing and commercialization models and the regulations drives the Europe Pharmaceutical Desiccant Market   . However, Asia-Pacific is projected to grow at the highest CAGR. Growing manufacturing activities and ageing population driving the growth of the market.

Related Report@ https://www.marketresearchfuture.com/reports/halogen-free-flame-retardant-market-6062

https://www.marketresearchfuture.com/reports/water-soluble-paints-market-5762

https://www.marketresearchfuture.com/reports/mold-release-agent-5019

https://www.marketresearchfuture.com/reports/polyester-coatings-market-5263

Pharmaceutical Desiccant Market Share, Size, Analysis, Growth, Trends and Forecast by 2027

 

Global Pharmaceutical Desiccant Market   - Overview

The pharmaceutical desiccant market is very dynamic in nature and is expected to witness high growth over the forecast period. The growth of the pharmaceutical desiccant market is influenced by growing pharmaceutical industry, increase in ageing population, and government initiative for pharmaceutical industry whereas it is hindered by the stringent regulations and temperature fluctuation.  

The continuous growth in the pharmaceutical industry is fuelling the overall growth of the pharmaceutical desiccant market. The rapid growth of the pharmaceutical market is mainly driven by the rising income and economic gains. The rise in the income, especially for the lower income level, along with the government commitments for providing basic health facilities, will make medicines available and affordable for the population. This will lead to the growth of pharmaceutical industry and indirectly will lead to more usage of pharmaceutical desiccant.

Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/4182

The rise in the ageing population leads to increasing diseases and more requirement of medical facilities in the population. This will increase the usage of medical facilities and health care products. Due to this, there will be an increase in the production of pharmaceutical desiccants. People are becoming aware about the diseases occurring due to growing age and are using the products which are healthy for them.

Government of India has taken various initiatives to ensure the approval, safety and marketing of quality drugs. The Central Drug Standards and Control Organization (CDSCO) provides the standards and measures for safety of the drugs, and ensures quality of the drug. It also regulates the market authorization of new drugs and approves the license for the manufacture of the drug. Due to the above regulatory bodies, there is an increase in the reliability of pharmaceutical products, which has resulted in the increased use of pharmaceutical desiccants. 

Key Players:

E. I. du Pont de Nemours and Company (U.S.), Multisorb Technologies (U.S.), Sanner GmbH (Germany), CSP Technologies, Inc (U.S.), Capitol Scientific, Inc (U.S.), Desiccare, Inc (U.S.), W. R. Grace & Co (U.S.), Desican Inc (U.S.), Clariant Global (Switzerland), and Oker-Chemie GmbH (Germany) are some of the prominent players at the forefront of competition in the global pharmaceutical desiccant market and are profiled in MRFR Analysis.

Global Pharmaceutical Desiccant Market   - Competitive Analysis

The major market players adopted various strategies to retain and/or expand their market share. Key strategies followed by most companies within the global pharmaceutical desiccant market were new product development. T

he major players operating in this market, to have adopted these strategies are E. I. du Pont de Nemours and Company (U.S.), Multisorb Technologies (U.S.), Sanner GmbH (Germany), CSP Technologies, Inc (U.S.), Capitol Scientific, Inc (U.S.), Desiccare, Inc (U.S.), W. R. Grace & Co (U.S.), Desican Inc (U.S.), Clariant Global (Switzerland), Oker-Chemie GmbH (Germany) and others. This strategy is widely adopted to increase the number of offerings to the customer. New innovations in the technology of manufacturing desiccants also lead to new product developments.      

During the period 2014-2016, amongst all the key developments, E. I. du Pont de Nemours and Company (U.S.) had the largest share of the merger and acquisition strategy. For instance, E. I. du Pont de Nemours and Company (U.S.) acquired Taxon Biosciences, Inc. (California), a leading microbiome discovery company. This acquisition will build on DuPont’s in-house capabilities and unparalleled market access in both seed and crop protection to discover and commercialize biological solutions for agriculture customers globally. The unique technology platform of Taxon Biosciences, Inc. coupled with DuPont’s robust research capabilities and positioning across several markets makes, the integration of Taxon into DuPont, a natural fit and will support DuPont’s ability to bring new products to the market, faster.

Clariant Global adopted joint ventures as its key strategy. The company has undergone joint ventures with ASK Group, Scientific Design Company Inc., Süd-Chemie India Pvt Ltd and others. For instance, the company underwent a joint venture with Scientific Design Company Inc., U.S., a producer of ethylene and oxide catalysts, which is co-owned by the Saudi Arabia-based, Sabic Group and has around 140 employees.

CSP Technologies, Inc. adopted new product development as its key strategy. For instance, the company introduced Pharmapuck™ Scavenging Devices, an Integrated Solution for Oral Solid Dose Products. It can be integrated directly into primary containers to protect oral solid dose (OSD) products from moisture and oxygen absorption.

Global Pharmaceutical Desiccant Market   - Segments

Global Pharmaceutical Desiccant Market is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.

Segmentation By Type: Comprises – Silica Gel, Activated, Carbonclay Desiccant, Molecular Sieves and Others

Segmentation By End-use:  Comprises – Tablets, API’s, Capsules, Diagnostic Kit and Nutraceutical Product Packaging

Segmentation By Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World

Global Pharmaceutical Desiccant Market   - Regional Analysis

On the basis of region, North America region dominates the pharmaceutical desiccant market. High adoption of desiccants for pharmaceutical and chemical sectors helped the North America desiccant market stay ahead of other regional markets.

Europe was the second-largest market in 2015. Latest developments in healthcare sector and the strategies behind them to new marketing and commercialization models and the regulations drives the Europe pharmaceutical desiccant market. However, Asia-Pacific is projected to grow at the highest CAGR. Growing manufacturing activities and ageing population driving the growth of the market.

Browse Full Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-desiccant-market-4182

Pharmaceutical Desiccant Market | Research, Competitor Strategy, Industry Trends and Forecast to 2027

 Market Research Future Published a Cooked Research Report on Global Pharmaceutical Desiccant Market Research Report – Forecast to 2027

Market Synopsis:

The product is used for absorbing the moisture so that it sustains a standard level of dryness. The growth of the pharmaceutical industry is likely to boost the revenue creation for the players of the pharmaceutical desiccant market in the years to come. In addition, the increasing production of medicines is poised to favor market growth over the next couple of years.

The rising demand for healthcare services, in conjunction with the increasing burden of chronic diseases, is prognosticated to catapult pharmaceutical desiccant market on upward trajectory. Also, the increasing research & development for drug discovery is projected to influence the expansion of the market positively.

Pharmaceutical desiccants are extensively used for extending the lifespan of medicines. According to Market Research Future (MRFR)’s recent analysis, the global pharmaceutical desiccant market is expected to touch a valuation of USD 191.3 Mn by 2023 exhibiting a CAGR of 4.43% during the assessment period.

Market Segmentation:

Based on type, the global pharmaceutical desiccant market has been segmented into silica gel, carbon clay desiccant, activated, molecular sieves and others. The silica gel segment dominated the growth trajectory of the market in 2015 with around 40% market share under its control. The segment was valued at USD 47.2 Mn in 2015 and is prognosticated to expand at 4.9% CAGR over the forecast period. The product is capable of absorbing high levels of moisture which is expected to drive the proliferation of the segment in the years to come. The activated segment was the second leading segment and was valued at over USD 29 Mn in 2015. It is anticipated to strike a CAGR of 4.16% across the projection period. The product is used for purification and moisture removal.

By End-Use, the pharmaceutical desiccant market has been segmented into tablets, API’s, diagnostic kit, capsules, and nutraceutical product packaging. The tablets segment accounted for the major share of 22% in 2015 and was valued at USD over 200 Mn. It is forecasted to mark a CAGR of 4.85% during the review period. The API segment is projected to gain traction in the forthcoming years. It scaled a valuation of USD 203.5 Mn in 2015 and is projected to register a CAGR of 4.37% over the forecast period.

Competitive Dashboard:

·       Multisorb Technologies

·       E. I. du Pont de Nemours and Company

·       Sanner GmbH

·       Capitol Scientific, Inc

·       Desiccare, Inc

·       CSP Technologies, Inc

·       W. R. Grace & Co

·       Clariant Global

·       Oker-Chemie GmbH

·       Desican Inc

Regional Analysis:

The global pharmaceutical desiccant market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America held the largest share of the market in 2015 which accounted for around 30% share. The regional segment was valued at USD 35.5 Mn and is anticipated to strike a CAGR of 4.37% over the assessment period. The pharmaceutical industry, as well as the chemical industry, has been observing an upsurge in demand for desiccants. This, in turn, is poised to drive the growth of the regional pharmaceutical desiccant market over the next couple of years.

Europe was valued at USD 31.9 Mn in 2015 and is likely to maintain its second spot over the next few years. The rapid developments in the healthcare sector of the region, coupled with new commercialization models, are expected to boost revenue creation for the players of the pharmaceutical desiccant market in the region. On the other hand, Asia Pacific is anticipated to mark the highest CAGR of 4.67% across the assessment period.

COVID-19 Outbreak Impact on Renewable Chemicals Market@ https://www.marketresearchfuture.com/report/covid-19-impact-renewable-chemicals-market

Pharmaceutical Desiccant Market | Research, Competitor Strategy, Industry Trends and Forecast to 2027

 Market Research Future Published a Cooked Research Report on Global Pharmaceutical Desiccant Market Research Report – Forecast to 2027

Market Synopsis:

The product is used for absorbing the moisture so that it sustains a standard level of dryness. The growth of the pharmaceutical industry is likely to boost the revenue creation for the players of the pharmaceutical desiccant market in the years to come. In addition, the increasing production of medicines is poised to favor market growth over the next couple of years.

The rising demand for healthcare services, in conjunction with the increasing burden of chronic diseases, is prognosticated to catapult pharmaceutical desiccant market on upward trajectory. Also, the increasing research & development for drug discovery is projected to influence the expansion of the market positively.

Pharmaceutical desiccants are extensively used for extending the lifespan of medicines. According to Market Research Future (MRFR)’s recent analysis, the global pharmaceutical desiccant market is expected to touch a valuation of USD 191.3 Mn by 2023 exhibiting a CAGR of 4.43% during the assessment period.

Market Segmentation:

Based on type, the global pharmaceutical desiccant market has been segmented into silica gel, carbon clay desiccant, activated, molecular sieves and others. The silica gel segment dominated the growth trajectory of the market in 2015 with around 40% market share under its control. The segment was valued at USD 47.2 Mn in 2015 and is prognosticated to expand at 4.9% CAGR over the forecast period. The product is capable of absorbing high levels of moisture which is expected to drive the proliferation of the segment in the years to come. The activated segment was the second leading segment and was valued at over USD 29 Mn in 2015. It is anticipated to strike a CAGR of 4.16% across the projection period. The product is used for purification and moisture removal.

By End-Use, the pharmaceutical desiccant market has been segmented into tablets, API’s, diagnostic kit, capsules, and nutraceutical product packaging. The tablets segment accounted for the major share of 22% in 2015 and was valued at USD over 200 Mn. It is forecasted to mark a CAGR of 4.85% during the review period. The API segment is projected to gain traction in the forthcoming years. It scaled a valuation of USD 203.5 Mn in 2015 and is projected to register a CAGR of 4.37% over the forecast period.

Competitive Dashboard:

·       Multisorb Technologies

·       E. I. du Pont de Nemours and Company

·       Sanner GmbH

·       Capitol Scientific, Inc

·       Desiccare, Inc

·       CSP Technologies, Inc

·       W. R. Grace & Co

·       Clariant Global

·       Oker-Chemie GmbH

·       Desican Inc

Regional Analysis:

The global pharmaceutical desiccant market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America held the largest share of the market in 2015 which accounted for around 30% share. The regional segment was valued at USD 35.5 Mn and is anticipated to strike a CAGR of 4.37% over the assessment period. The pharmaceutical industry, as well as the chemical industry, has been observing an upsurge in demand for desiccants. This, in turn, is poised to drive the growth of the regional pharmaceutical desiccant market over the next couple of years.

Europe was valued at USD 31.9 Mn in 2015 and is likely to maintain its second spot over the next few years. The rapid developments in the healthcare sector of the region, coupled with new commercialization models, are expected to boost revenue creation for the players of the pharmaceutical desiccant market in the region. On the other hand, Asia Pacific is anticipated to mark the highest CAGR of 4.67% across the assessment period.

COVID-19 Outbreak Impact on Renewable Chemicals Market@ https://www.marketresearchfuture.com/report/covid-19-impact-renewable-chemicals-market

Pharmaceutical Desiccant Market Global Industry Review, Research, Statistics, And Growth To 2023

Market Insights:

Pharmaceutical Desiccant are extensively used for extending the lifespan of medicines. According to Market Research Future (MRFR)’s recent analysis, the global Pharmaceutical Desiccant Market is expected to touch a valuation of USD 191.3 Mn by 2023 exhibiting a CAGR of 4.43% during the assessment period.

The product is used for absorbing the moisture so that it sustains a standard level of dryness. The growth of the Pharmaceutical Desiccant Market is likely to boost the revenue creation for the players of the Pharmaceutical Desiccant Packaging in the years to come. In addition, the increasing production of medicines is poised to favor market growth over the next couple of years.

The rising demand for healthcare services, in conjunction with the increasing burden of chronic diseases, is prognosticated to catapult Pharmaceutical Desiccant Market on upward trajectory. Also, the increasing research & development for drug discovery is projected to influence the expansion of the market positively.

Competitive Dashboard:

·         Multisorb Technologies

·         E. I. du Pont de Nemours and Company

·         Sanner GmbH

·         Capitol Scientific, Inc

·         Desiccare, Inc

·         CSP Technologies, Inc

·         W. R. Grace & Co

·         Clariant Global

·         Oker-Chemie GmbH

·         Desican Inc

Market Segmentation:

Based on type, the global Pharmaceutical Desiccant Market has been segmented into silica gel, carbon clay desiccant, activated, molecular sieves and others. The silica gel segment dominated the growth trajectory of the market in 2015 with around 40% market share under its control. The segment was valued at USD 47.2 Mn in 2015 and is prognosticated to expand at 4.9% CAGR over the forecast period. The product is capable of absorbing high levels of moisture which is expected to drive the proliferation of the segment in the years to come. The activated segment was the second leading segment and was valued at over USD 29 Mn in 2015. It is anticipated to strike a CAGR of 4.16% across the projection period. The product is used for purification and moisture removal.

By End-Use, the Pharmaceutical Desiccant Market has been segmented into tablets, API’s, diagnostic kit, capsules, and nutraceutical product packaging. The tablets segment accounted for the major share of 22% in 2015 and was valued at USD over 200 Mn. It is forecasted to mark a CAGR of 4.85% during the review period. The API segment is projected to gain traction in the forthcoming years. It scaled a valuation of USD 203.5 Mn in 2015 and is projected to register a CAGR of 4.37% over the forecast period.

Regional Analysis:

The global Pharmaceutical Desiccant Market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America held the largest share of the market in 2015 which accounted for around 30% share. The regional segment was valued at USD 35.5 Mn and is anticipated to strike a CAGR of 4.37% over the assessment period. The pharmaceutical industry, as well as the chemical industry, has been observing an upsurge in demand for desiccants. This, in turn, is poised to drive the growth of the regional Pharmaceutical Desiccant Market over the next couple of years.

Europe was valued at USD 31.9 Mn in 2015 and is likely to maintain its second spot over the next few years. The rapid developments in the healthcare sector of the region, coupled with new commercialization models, are expected to boost revenue creation for the players of the Pharmaceutical Desiccant Market in the region. On the other hand, Asia Pacific is anticipated to mark the highest CAGR of 4.67% across the assessment period.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-desiccant-market-4182

Pharmaceutical Desiccant Market Global Industry Review, Research, Statistics, And Growth To 2023

Market Insights:

Pharmaceutical Desiccant are extensively used for extending the lifespan of medicines. According to Market Research Future (MRFR)’s recent analysis, the global pharmaceutical desiccant market is expected to touch a valuation of USD 191.3 Mn by 2023 exhibiting a CAGR of 4.43% during the assessment period.

The product is used for absorbing the moisture so that it sustains a standard level of dryness. The growth of the pharmaceutical Desiccant Industry is likely to boost the revenue creation for the players of the Pharmaceutical Desiccant Packaging in the years to come. In addition, the increasing production of medicines is poised to favor market growth over the next couple of years.

The rising demand for healthcare services, in conjunction with the increasing burden of chronic diseases, is prognosticated to catapult pharmaceutical desiccant market on upward trajectory. Also, the increasing research & development for drug discovery is projected to influence the expansion of the market positively.

Competitive Dashboard:

·         Multisorb Technologies

·         E. I. du Pont de Nemours and Company

·         Sanner GmbH

·         Capitol Scientific, Inc

·         Desiccare, Inc

·         CSP Technologies, Inc

·         W. R. Grace & Co

·         Clariant Global

·         Oker-Chemie GmbH

·         Desican Inc

Market Segmentation:

Based on type, the global Pharmaceutical Desiccant Market has been segmented into silica gel, carbon clay desiccant, activated, molecular sieves and others. The silica gel segment dominated the growth trajectory of the market in 2015 with around 40% market share under its control. The segment was valued at USD 47.2 Mn in 2015 and is prognosticated to expand at 4.9% CAGR over the forecast period. The product is capable of absorbing high levels of moisture which is expected to drive the proliferation of the segment in the years to come. The activated segment was the second leading segment and was valued at over USD 29 Mn in 2015. It is anticipated to strike a CAGR of 4.16% across the projection period. The product is used for purification and moisture removal.

By End-Use, the pharmaceutical desiccant market has been segmented into tablets, API’s, diagnostic kit, capsules, and nutraceutical product packaging. The tablets segment accounted for the major share of 22% in 2015 and was valued at USD over 200 Mn. It is forecasted to mark a CAGR of 4.85% during the review period. The API segment is projected to gain traction in the forthcoming years. It scaled a valuation of USD 203.5 Mn in 2015 and is projected to register a CAGR of 4.37% over the forecast period.

Regional Analysis:

The global pharmaceutical desiccant market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America held the largest share of the market in 2015 which accounted for around 30% share. The regional segment was valued at USD 35.5 Mn and is anticipated to strike a CAGR of 4.37% over the assessment period. The pharmaceutical industry, as well as the chemical industry, has been observing an upsurge in demand for desiccants. This, in turn, is poised to drive the growth of the regional pharmaceutical desiccant market over the next couple of years.

Europe was valued at USD 31.9 Mn in 2015 and is likely to maintain its second spot over the next few years. The rapid developments in the healthcare sector of the region, coupled with new commercialization models, are expected to boost revenue creation for the players of the pharmaceutical desiccant market in the region. On the other hand, Asia Pacific is anticipated to mark the highest CAGR of 4.67% across the assessment period.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/pharmaceutical-desiccant-market-4182